Skip to main content

News

November 20, 2020
Lightning 12 and Separator 12 Now Indicated for Treatment of PE
November 17, 2020
At this year’s Vascular Interventional Advances (VIVA) conference, Dr. Anthony Comerota presented data on the Zilver® Vena™ Venous Self-Expanding Stent that demonstrates durable patency and symptom relief in patients over an extended period of time.
November 16, 2020
Control Medical and TZ Medical announced an exclusive distribution agreement for the United States for the Control Medical Mechanical Thrombectomy System.
November 16, 2020
The new FDA-cleared XO Score® system was successfully used to dilate multiple challenging fibrotic and calcific lesions in hemodialysis patients with stenotic and occluded fistulas.
November 16, 2020
medQ Inc, a leading provider of automated imaging workflow solutions, has signed a strategic partnership agreement with Shina Systems Ltd., a market leader in imaging applications and AI open platform PACS solutions.
November 16, 2020
Cardiovascular Institute of the South is the only facility in Louisiana that has been awarded Gold Status by the American Heart Association and the American Medical Association for its commitment to keeping patient blood pressure rates under control…
November 11, 2020
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that 10 data presentations will be shared at the virtual American Heart Association (AHA) Scientific Sessions 2020 from November 13-17. Most notably, four new sub-analyses…
November 11, 2020
AstraZeneca’s BRILINTA® (ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score ≤5) or high-…
November 09, 2020
Twelve-Month Results Presented in Late-Breaking Trials Session at Vascular Interventional Advances (VIVA) Conference PARIS – November 9, 2020 — LimFlow SA, the pioneer in the development of minimally-invasive technology for the treatment of chronic…
November 09, 2020
hockwave Medical, Inc., offering Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, reported today that investigators unveiled data from the Disrupt PAD III study, which showed IVL to be superior to percutaneous…
November 09, 2020
Concept Medical Inc., focused on vascular intervention drug delivery devices, has announced the enrollment of the first patient in the SirPAD (Sirolimus in Peripheral Artery Disease) trial.
Back to Top